Donald W. Landry, M.D.
Associate Professor of Medicine. Columbia University; Director, Division of Clinical Pharmacology & Experimental Therapeutics, Department of Medicine

Donald W. Landry, M.D., completed his Ph.D. in organic chemistry under Nobel laureate Robert Burns Woodward at Harvard University in 1979 and then obtained the M.D. degree from Columbia University in 1983. After completing his Residency in Internal Medicine at the Massachusetts General Hospital, he returned to Columbia University as a NIH Physician-Scientist, 1985-90. In 1991, he established a laboratory at Columbia University to investigate medical applications of artificial enzymes and was the first to develop a catalytic antibody to degrade cocaine. He is presently an Associate Professor of Medicine and Director, Division of Clinical Pharmacology and Experimental Therapeutics in the Department of Medicine at Columbia University, College of Physicians & Surgeons.